Charles Williams Flexner

Professor

1976 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Anti-HIV Agents Medicine & Life Sciences
Drug Interactions Medicine & Life Sciences
efavirenz Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1976 2018

Antiretroviral implants for treatment and prevention of HIV infection

Flexner, C. Jul 1 2018 In : Current Opinion in HIV and AIDS. 13, 4, p. 374-380 7 p.

Research output: Contribution to journalReview article

HIV Infections
Drug Implants
Technology
Nevirapine
Protective Agents

Long-acting formulations for the treatment of latent tuberculous infection: Opportunities and challenges

Swindells, S., Siccardi, M., Barrett, S. E., Olsen, D. B., Grobler, J. A., Podany, A. T., Nuermberger, E., Kim, P., Barry, C. E., Owen, A., Hazuda, D. & Flexner, C., Feb 1 2018, In : International Journal of Tuberculosis and Lung Disease. 22, 2, p. 125-132 8 p.

Research output: Contribution to journalReview article

Tuberculosis
Infection
HIV
Drug Compounding
Virus Diseases

Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study

Rajoli, R. K. R., Podany, A. T., Moss, D. M., Swindells, S., Flexner, C., Owen, A. & Siccardi, M., Aug 1 2018, In : International Journal of Tuberculosis and Lung Disease. 22, 8, p. 937-944 8 p.

Research output: Contribution to journalArticle

rifapentine
bedaquiline
Tuberculosis
Pharmacokinetics
Isoniazid

Compatibility of next-generation first-line antiretrovirals with rifampicin-based antituberculosis therapy in resource limited settings

Maartens, G., Boffito, M. & Flexner, C., Apr 11 2017, (Accepted/In press) In : Current Opinion in HIV and AIDS.

Research output: Contribution to journalArticle

efavirenz
Rifampin
Drug Interactions
Tenofovir
Therapeutics

In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents

Rajoli, R. K. R., Back, D. J., Rannard, S., Meyers, C. F., Flexner, C., Owen, A. & Siccardi, M., May 24 2017, (Accepted/In press) In : Clinical Pharmacokinetics. p. 1-12 12 p.

Research output: Contribution to journalArticle

Rilpivirine
Computer Simulation
Pharmacokinetics
Injections
Physiological Phenomena